Pump design could give new hope to heart patients

A new counter-flow heart pump being developed by Queensland University of Technology has the potential to revolutionise future designs of the mechanical heart. Lead researcher Associate Professor Andy Tan said the heart pump's innovative design was based on a doubleoutput centrifugal model that pushed the blood in a counter direction to ensure correct flow through both sides of the heart, and is the subject of a patent application.

"The counter-flow pump is a bi-ventricular assist device (BVAD), meaning it supports both the left and right sides of the heart simultaneously," he said. "But what's so groundbreaking is that it is the first device to combine the function of two pumps into one unit. Professor Tan said current double heart pump technology was too bulky because it required the implant of two pumps that worked independently.

"The problem with two pumps is that it requires different controllers and can potentially lead to an uneven blood flow.

"The concept of the counter-flow pump is that it has two independent impellers to simulate two pumps to augment the operations of the left and right ventricles but is essential only one. "Using independent impellers, the blood is able to flow at a higher delivery pressure as required by the left chamber of the heart, and a slower pressure as required by the right chamber of the heart."

Professor Tan said a shortage of heart donors and high rates of cardiovascular disease were driving scientists across the globe to develop the technology for a replacement heart. "Each year in Australia, 44 per cent of all deaths are related to heart disease," Professor Tan said. "In fact heart failure, stroke and vascular disease kill more Australians than any other disease group. To reduce the number of deaths, treatment is now focused on medical devices that can assist or totally replicate the function of the heart."

He said a heart pump capable of supporting both chambers would dramatically increase patients' chance of survival. "Clinical studies around the world have found that patients who received a permanent left heart pump (left ventricular assist device) reduced their risk of dying within one year by 47 per cent," Professor Tan said. "Unfortunately 25 per cent of these patients went on to develop right heart failure syndrome, infection and multiorgan failure. We have developed the design, and computer modelling has shown that it works."

Source: Queensland University of Technology

Related stories:

Pump design could give heart patients new hope
A new counter-flow heart pump being developed by Queensland University of Technology has the potential to revolutionize future designs of the mechanical heart.
The beat goes on: Artificial heart technology holds promise for alternatives
Patients on the waiting list for a heart transplant soon may have more options thanks to a new device being developed by the Texas Heart Institute in collaboration with two University of Houston professors.
Fabless future: Struggling AMD spins off factories
(AP) -- For years, Advanced Micro Devices Inc.'s scrappy image was best summed up by an insult that founder Jerry Sanders lobbed against rivals: "Real men have fabs."
Answering the question: Who should have surgery for sleep apnea?
Even as more and more people in the United States are diagnosed with obstructive sleep apnea (OSA), there remains a disconnect as to who can benefit from corrective surgery. Leading experts in the field of sleep medicine will attempt to answer the question of who could benefit from surgery, during a moderated discussion at the 2008 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in Chicago, IL.
New mechanism for cardiac arrhythmia discovered
It has long been thought that virus infections can cause cardiac arrhythmia. But why has not been understood. Ulrike Lisewski, Dr. Yu Shi, Michael Radke and Professor Michael Gotthardt of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have now discovered the molecular mechanism. The researchers demonstrated that the receptor which the virus uses to infect heart cells is normally necessary for regular heart beat in mice.
Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results
Engineers at the Georgia Institute of Technology have developed a prosthetic vein valve to help improve the lives of those suffering from a condition known as chronic venous insufficiency. The condition, which affects more than seven million people in the United States alone, occurs when valves in a person's veins can no longer ensure a one-way flow of blood back to the heart.
New nano device detects immune system cell signaling
Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances.
High-Tech 'Heart' of New-Generation Radio Telescope Passes First Test
The Expanded Very Large Array (EVLA), part of the National Radio Astronomy Observatory (NRAO), took a giant step toward completion on August 7 with successful testing of advanced digital hardware designed to combine signals from its upgraded radio-telescope antennas to produce high resolution images of celestial objects.

News discussion:

Medicine & Health news